Orbimed Advisors LLC Portfolio Holdings

Orbimed Advisors LLC

  • $3.69 Billion
  • Q4 2024

Orbimed Advisors LLC has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $3.69 Billion distributed in 119 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Edgewise Therapeutics, Inc. with a value of $401M, Boston Scientific Corp with a value of $282M, Eli Lilly & CO with a value of $261M, Intuitive Surgical Inc with a value of $210M, and Neurocrine Biosciences Inc with a value of $128M.

Examining the 13F form we can see an decrease of $551M in the current position value, from $4.24B to 3.69B.

Orbimed Advisors LLC is based out at San Diego, CA

Below you can find more details about Orbimed Advisors LLC portfolio as well as his latest detailed transactions.

Portfolio value $3.69 Billion
Healthcare: $3.66 Billion
ETFs: $33.5 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$1.71B
$401 Million 10.86% of portfolio
15,021,721
Q1 2024 Added 3.12%
$151B
$282 Million 7.65% of portfolio
3,160,300
Q4 2024 Reduced 3.44%
$830B
$261 Million 7.06% of portfolio
337,600
Q2 2024 Reduced 6.43%
$214B
$210 Million 5.68% of portfolio
401,700
Q4 2024 Reduced 7.4%
$11.1B
$128 Million 3.47% of portfolio
938,120
Q4 2024 Added 210.41%
$146B
$124 Million 3.36% of portfolio
344,400
Q3 2024 Added 28.03%
$9.49B
$117 Million 3.17% of portfolio
963,400
Q4 2024 Added 0.93%
$35.8B
$117 Million 3.16% of portfolio
189,700
Q4 2024 Reduced 7.24%
$14.8B
$100 Million 2.71% of portfolio
792,000
Q4 2024 Added 1.28%
$4.64B
$98.5 Million 2.67% of portfolio
2,817,347
Q4 2024 Added 21.21%
$30.9B
$97.8 Million 2.65% of portfolio
415,600
Q4 2024 Added 66.04%
$46.2B
$84.8 Million 2.3% of portfolio
1,145,302
Q4 2024 New
$222B
$82.6 Million 2.24% of portfolio
829,900
Q4 2024 Reduced 36.94%
$19.7B
$77.9 Million 2.11% of portfolio
509,100
Q4 2024 Reduced 37.38%
$4.48B
$76.2 Million 2.06% of portfolio
575,000
Q3 2024 Added 64.65%
$4.81B
$74.5 Million 2.02% of portfolio
1,584,005
Q4 2024 Added 106.54%
$16.3B
$65.4 Million 1.77% of portfolio
413,000
Q4 2024 Reduced 39.93%
$123B
$60.8 Million 1.65% of portfolio
151,000
Q2 2024 Added 23.06%
$142M
$59.5 Million 1.61% of portfolio
5,779,071
Q3 2022 New
$2.01B
$51.1 Million 1.38% of portfolio
999,000
Q4 2024 Reduced 4.86%
$617M
$48.3 Million 1.31% of portfolio
3,442,853
Q4 2024 Added 4.15%
$12.1B
$48.3 Million 1.31% of portfolio
269,300
Q4 2024 Added 72.63%
$3.74B
$45.3 Million 1.23% of portfolio
1,255,031
Q4 2024 Reduced 9.75%
$211B
$43.9 Million 1.19% of portfolio
84,400
Q3 2024 Reduced 36.06%
$155M
$42.2 Million 1.14% of portfolio
7,562,971
Q3 2024 Reduced 0.74%
$1.55B
$40.6 Million 1.1% of portfolio
758,566
Q4 2024 Reduced 39.73%
$354M
$38.1 Million 1.03% of portfolio
3,406,335
Q2 2024 Reduced 14.93%
$8.76B
$38.2 Million 1.03% of portfolio
679,816
Q3 2024 Added 1.1%
$2.45B
$37.2 Million 1.01% of portfolio
947,877
Q4 2024 Added 4.0%
$198M
$36.1 Million 0.98% of portfolio
6,943,654
Q3 2021 Reduced 13.78%
$61.7M
$33.6 Million 0.91% of portfolio
73,114,592
Q3 2022 Added 0.23%
$0
$33.5 Million 0.91% of portfolio
372,000
Q4 2024 New
$1.7B
$32.4 Million 0.88% of portfolio
1,112,886
Q4 2024 Added 6.52%
$312M
$32.4 Million 0.88% of portfolio
22,362,850
Q4 2022 Added 1.83%
$801M
$31.4 Million 0.85% of portfolio
742,572
Q4 2024 Added 9.87%
$724M
$28.9 Million 0.78% of portfolio
1,227,080
Q4 2024 Added 73.22%
$1.3B
$23.6 Million 0.64% of portfolio
3,218,617
Q4 2024 Reduced 9.92%
$417M
$23.7 Million 0.64% of portfolio
1,942,555
Q4 2024 Added 81.54%
$138B
$22.7 Million 0.61% of portfolio
245,600
Q4 2024 Added 61.9%
$3.21B
$22.4 Million 0.61% of portfolio
400,000
Q4 2024 Reduced 8.24%
$351M
$22 Million 0.59% of portfolio
3,087,462
Q4 2024 Added 53.88%
$92.1M
$21.5 Million 0.58% of portfolio
6,059,528
Q3 2024 Added 8.99%
$2.54B
$21.5 Million 0.58% of portfolio
2,285,400
Q4 2024 Added 300.74%
$37.4M
$20.8 Million 0.56% of portfolio
13,135,260
Q4 2024 New
$536M
$20.4 Million 0.55% of portfolio
1,470,086
Q4 2024 Added 91.26%
$284M
$16.1 Million 0.44% of portfolio
1,018,734
Q3 2024 Reduced 19.7%
$146M
$15.8 Million 0.43% of portfolio
4,377,900
Q3 2024 Added 189.34%
$10.7B
$14.9 Million 0.4% of portfolio
44,900
Q3 2024 New
$32.7M
$13.9 Million 0.38% of portfolio
10,909,256
Q2 2023 Added 8.66%

Summary

  • Portfolio
  • No. of Stocks 119
  • Current Value $3.69 Billion
  • Prior Value $4.24 Billion
  • Filing
  • Period Q4 2024
  • Filing Date February 14, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 20 stocks
  • Additional Purchases 23 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 21 stocks
Track This Portfolio

Track Orbimed Advisors LLC Portfolio

Follow Orbimed Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email